BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Razonable RR. Cytomegalovirus infection after liver transplantation: Current concepts and challenges. World J Gastroenterol 2008; 14(31): 4849-4860 [PMID: 18756591 DOI: 10.3748/wjg.14.4849]
URL: https://www.wjgnet.com/1007-9327/full/v14/i31/4849.htm
Number Citing Articles
1
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Oriol Bestard, Josep M. Cruzado, Edoardo Melilli, Joan Torras, Josep M. Grinyó, Nuria Lloberas, Helena Colom. Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachClinical Pharmacokinetics 2023; 62(6): 861 doi: 10.1007/s40262-023-01237-3
2
Jay A. Fishman, Robin K. Avery. Textbook of Organ Transplantation2014; : 1117 doi: 10.1002/9781118873434.ch94
3
G. Erwin Buckel, G. Andrea Alba. Dieciséis años de experiencia de trasplante hepático en clínica las condesRevista Médica Clínica Las Condes 2010; 21(2): 267 doi: 10.1016/S0716-8640(10)70533-2
4
Michael Barry. Single-cycle adenovirus vectors in the current vaccine landscapeExpert Review of Vaccines 2018; : 1 doi: 10.1080/14760584.2018.1419067
5
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases2019; : 41 doi: 10.1007/978-1-4939-9034-4_3
6
Narendra S. Choudhary, Sanjiv Saigal, Rajat Shukla, Hardik Kotecha, Neeraj Saraf, Arvinder S. Soin. Current Status of Immunosuppression in Liver TransplantationJournal of Clinical and Experimental Hepatology 2013; 3(2): 150 doi: 10.1016/j.jceh.2013.04.005
7
R.J. Arasaratnam, I. Tzannou, T. Gray, P.I. Aguayo-Hiraldo, M. Kuvalekar, S. Naik, A. Gaikwad, H. Liu, T. Miloh, J.F. Vera, R.W. Himes, F.M. Munoz, A.M. Leen. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipientsAmerican Journal of Transplantation 2018; 18(9): 2238 doi: 10.1111/ajt.14967
8
Nurettin Dogan, Anna Hüsing-Kabar, Hartmut H. Schmidt, Vito R. Cicinnati, Susanne Beckebaum, Iyad Kabar. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failureJournal of International Medical Research 2018; 46(9): 3979 doi: 10.1177/0300060518785543
9
Augustine J. Sohn, Hoonbae Jeon, Joseph Ahn. Primary Care of the Liver Transplant RecipientPrimary Care: Clinics in Office Practice 2011; 38(3): 499 doi: 10.1016/j.pop.2011.05.006
10
Sari R. Freedman, Kenneth Saunders, Michael E. Plazak, Bharath R. Ravichandran, Kapil K. Saharia, Brian M. Masters, Tracy Sparkes. Impact of high MELD scores on CMV viremia following liver transplantationTransplant Infectious Disease 2023; 25(1) doi: 10.1111/tid.14001
11
Shanna Kowalsky, Ronen Arnon, Roberto Posada. Prevention of cytomegalovirus following solid organ transplantation: A literature reviewPediatric Transplantation 2013; 17(6): 499 doi: 10.1111/petr.12118
12
David Herman, Hyosun Han. Cytomegalovirus in liver transplant recipientsCurrent Opinion in Organ Transplantation 2017; 22(4): 345 doi: 10.1097/MOT.0000000000000433
13
Yuliang Wang, Yawu Liu, Ruifa Han, Qiang Li, Zhi Yao, Wenyan Niu, Yuhua Yuan, Zhiqin Tang, Zhijun Zhu, Zhongyang Shen. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantationJournal of Gastroenterology and Hepatology 2010; 25(1): 138 doi: 10.1111/j.1440-1746.2009.05966.x
14
T. Coulson, J. Wendon. Réanimation hépatosplanchnique2010; : 61 doi: 10.1016/B978-2-8101-0186-3.50004-7
15
Curtis D. Holt, Drew J. Winston. Transplantation of the Liver2015; : 1006 doi: 10.1016/B978-1-4557-0268-8.00078-6
16
Anita S. Chong, Maria-Luisa Alegre. The impact of infection and tissue damage in solid-organ transplantationNature Reviews Immunology 2012; 12(6): 459 doi: 10.1038/nri3215
17
Udayakumar Navaneethan, Preethi G.K. Venkatesh, Jiang Wang. Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBDJournal of Crohn's and Colitis 2011; 5(4): 354 doi: 10.1016/j.crohns.2011.01.010
18
Qingbao Ding, Keyu Wang, Yupeng Li, Peng Peng, Dongyuan Zhang, Donglei Chang, Wentao Wang, Lei Ren, Fang Tang, Ziqiang Li. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver TransplantationAmerican Journal of Clinical Oncology 2023; 46(7): 284 doi: 10.1097/COC.0000000000001004
19
P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois. The complex interrelationships between chronic lung and liver disease: a reviewJournal of Viral Hepatitis 2010; 17(6): 381 doi: 10.1111/j.1365-2893.2010.01307.x
20
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7745-3_40-1
21
Lee R. Wright, Dennis L. Wright, Sandra K. Weller. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug DiscoveryViruses 2022; 14(7): 1557 doi: 10.3390/v14071557
22
Rohit Talwani, Bruce L. Gilliam, Charles Howell. Infectious Diseases and the LiverClinics in Liver Disease 2011; 15(1): 111 doi: 10.1016/j.cld.2010.09.002
23
C. Camus. Complications infectieuses chez le transplanté hépatiqueRéanimation 2014; 23(3): 317 doi: 10.1007/s13546-014-0888-7
24
G.W. Kang, H.L. Hong, I.H. Lee, K.S. Ahn, J.D. Kim, D.L. Choi. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case ReportTransplantation Proceedings 2016; 48(4): 1208 doi: 10.1016/j.transproceed.2016.01.021
25
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_32-1
26
Stefan G. Hübscher, Andrew D. Clouston. MacSween's Pathology of the Liver2012; : 853 doi: 10.1016/B978-0-7020-3398-8.00015-5
27
Fawaz D Alshammari. Association between HPV, CMV, EBV and HS Viruses and Breast Cancer in Saudi ArabiaJournal of Cancer Prevention & Current Research 2017; 7(3) doi: 10.15406/jcpcr.2017.07.00236
28
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patientsBoletín Médico del Hospital Infantil de México 2016; 73(1): 4 doi: 10.1016/j.bmhimx.2015.12.006
29
A.C. Guardia-Silva, R.S.B. Stucchi, A.M. Sampaio, A. Milan, S.C.B. Costa, I.F.S.F. Boin. Detection of Cytomegalovirus and Human Herpesvirus-6 DNA in Liver Biopsy Specimens and Their Correlation With Rejection After Liver TransplantationTransplantation Proceedings 2012; 44(8): 2441 doi: 10.1016/j.transproceed.2012.07.027
30
Yumi Aoyama, Seiko Sugiyama, Takenobu Yamamoto. Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the QuestionsPharmaceuticals 2022; 15(7): 797 doi: 10.3390/ph15070797
31
Amir Nasimfar, Ebrahim Sadeghi, Abdolvahab Alborzi, Nariman Sepehrvand, Mazyar Ziyaeyan, Marzieh Jamalidoust, Sayed Ali Malek-Hosseini. The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver TransplantationHepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.11987
32
W.C. Palmer, C.B. Taner, A.P. Keaveny, R.E. Nakhleh, J.H. Nguyen, B.G. Rosser. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver TransplantationTransplantation Proceedings 2018; 50(10): 3606 doi: 10.1016/j.transproceed.2018.09.001
33
Irmeli Lautenschlager. CMV infection, diagnosis and antiviral strategies after liver transplantationTransplant International 2009; 22(11): 1031 doi: 10.1111/j.1432-2277.2009.00907.x
34
Raymund R. Razonable, Ajit P. Limaye. Transplant Infections2016; : 441 doi: 10.1007/978-3-319-28797-3_25
35
John A. Zaia. Clinical Virology2016; : 75 doi: 10.1128/9781555819439.ch6
36
Nina Singh, Drew J Winston, Raymund R Razonable, G Marshall Lyon, Fernanda P Silveira, Marilyn M Wagener, Ajit P Limaye. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive DonorsClinical Infectious Diseases 2021; 73(9): e2739 doi: 10.1093/cid/ciaa1051
37
Omar J. BenMarzouk-Hidalgo, José M. Cisneros, Elisa Cordero, Almudena Martín-Peña, Berta Sanchez, Cecilia Martin-Gandul, Miguel A. Gentil, Miguel A. Gomez-Bravo, Ernesto Lage, Pilar Perez-Romero. Therapeutic Effect of the Acquisition of Cytomegalovirus-Specific Immune Response During Preemptive TreatmentTransplantation 2011; 91(8): 927 doi: 10.1097/TP.0b013e3182115ba2
38
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt. Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipientsJournal of Clinical Virology 2013; 57(1): 50 doi: 10.1016/j.jcv.2013.01.013
39
Balázs Nemes, György Gámán, Attila Doros. Biliary complications after liver transplantationExpert Review of Gastroenterology & Hepatology 2015; 9(4): 447 doi: 10.1586/17474124.2015.967761
40
Romil Saxena, M. Isabel Fiel. Practical Hepatic Pathology: a Diagnostic Approach2018; : 629 doi: 10.1016/B978-0-323-42873-6.00038-X
41
Leila Jalilsani, Ramin Yaghobi, Bita Geramizadeh, Afsoon Afshari, MohammadHossein Karimi. A New Duplication in 668 to 672 Sites of UL54 Gene in Cytomegalovirus Ganciclovir Resistant Liver Transplanted PatientsJundishapur Journal of Microbiology 2023; 16(9) doi: 10.5812/jjm-137970
42
Salman Khan, Timothy Sullivan, Mohsin Ali, Dallas Dunn, Gopi Patel, Shirish Huprikar. Low‐dose valganciclovir for cytomegalovirus prophylaxis in intermediate‐risk liver transplantation recipientsLiver Transplantation 2018; 24(5): 616 doi: 10.1002/lt.25047
43
Paulina Cybulska, Andy Ni, Carolina Jimenez-Rivera. Viral Hepatitis: Retrospective Review in a Canadian Pediatric HospitalISRN Pediatrics 2011; 2011: 1 doi: 10.5402/2011/182964
44
Marzieh Jamalidoust, Mandana Namayandeh, Gholamreza Pouladfar, Mazyar Ziyaeyan. Post-Liver Transplant Cytomegalovirus (CMV) Reactivation, Graft, and Patient Survival Rates in Iranian PopulationJundishapur Journal of Microbiology 2021; 14(3) doi: 10.5812/jjm.112775
45
Thomas V. Brogan, Francois Aspesberro. Diseases of the Liver in Children2014; : 463 doi: 10.1007/978-1-4614-9005-0_24
46
Ekta Gupta, Viniyendra Pamecha, Yogita Verma, Niteen Kumar, Archana Rastogi, Nadeem Hasnian, Ajeet Singh Bhadoria. Pre-Transplant Cytomegalovirus Immunoglobulin G Antibody Levels Could Prevent Severe Cytomegalovirus Infections Post-Transplant in Liver Transplant Recipients: Experience from a Tertiary Care Liver CentreIndian Journal of Medical Microbiology 2017; 35(4): 499 doi: 10.4103/ijmm.IJMM_17_201
47
Douglas Hunt, Sammy Saab. Zakim and Boyer's Hepatology2012; : 869 doi: 10.1016/B978-1-4377-0881-3.00049-8
48
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patientsBoletín Médico Del Hospital Infantil de México (English Edition) 2016; 73(1): 4 doi: 10.1016/S2444-3409(16)30012-7
49
Mark Pedersen, Anil Seetharam. Infections After Orthotopic Liver TransplantationJournal of Clinical and Experimental Hepatology 2014; 4(4): 347 doi: 10.1016/j.jceh.2014.07.004
50
Ângela Carvalho-Gomes, Almudena Cubells, Carmina Pallarés, Francisca Corpas-Burgos, Marina Berenguer, Victoria Aguilera, F. Xavier López-Labrador. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantationCellular Immunology 2022; 371: 104455 doi: 10.1016/j.cellimm.2021.104455
51
Eun-Ki Min, Juhan Lee, Su Jin Jeong, Deok-Gie Kim, Seung Hyuk Yim, Mun Chae Choi, Dong Jin Joo, Myoung Soo Kim, Jae Geun Lee. Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipientsInternational Journal of Infectious Diseases 2023; 131: 166 doi: 10.1016/j.ijid.2023.04.387
52
Michelle Teodoro Alves, Sandra Simone Vilaça, Lara Carvalho Godoi, Leonides Rezende Júnior, Maria das Graças Carvalho, Franciele de Souza Silva, Flávia Loli Guimarães, Ana Paula Fernandes, Luci Maria SantAna Dusse, Karina Braga Gomes. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapyClinica Chimica Acta 2014; 431: 52 doi: 10.1016/j.cca.2014.01.039
53
D. Kroy, C. Trautwein. Immunsuppression nach LebertransplantationDer Gastroenterologe 2018; 13(3): 195 doi: 10.1007/s11377-018-0252-y
54
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical ConsiderationsAnnals of Pharmacotherapy 2023; 57(5): 597 doi: 10.1177/10600280221118959
55
O. M. Tsiroulnikova, I. V. Zhilkin, D. G. Akhaladze. CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTSRussian Journal of Transplantology and Artificial Organs 2016; 18(1): 67 doi: 10.15825/1995-1191-2016-1-67-77
56
Sara Hafezi-Bakhtiari, Oyedele A. Adeyi. Evaluating and interpreting bile duct changes in liver allograft biopsiesDiagnostic Histopathology 2012; 18(2): 86 doi: 10.1016/j.mpdhp.2011.11.001
57
Yong-Hee Kim. Human Cytomegalovirus Infection in Solid-Organ TransplantationJournal of Bacteriology and Virology 2015; 45(1): 11 doi: 10.4167/jbv.2015.45.1.11
58
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesTransplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13898
59
Sang Hoon Han. Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention StrategiesInfection & Chemotherapy 2017; 49(3): 161 doi: 10.3947/ic.2017.49.3.161
60
Ramin Raul Ossami Saidy, Stefanie Kollar, Zoltan Czigany, Luca Dittrich, Nathanael Raschzok, Brigitta Globke, Wenzel Schöning, Robert Öllinger, Georg Lurje, Johann Pratschke, Dennis Eurich, Deniz Uluk. Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantationTransplant Infectious Disease 2024; 26(1) doi: 10.1111/tid.14196
61
Abdulkareem M Albekairy, Mohammad S Shawaqfeh, Shroug H Alharbi, Faisal Almuqbil, Mesfer A Alghamdi, Nataleen A Albekairy, Suhaib M Muflih, Abdulmalik Alkatheri. Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective EvaluationTransplant Research and Risk Management 2022; : 35 doi: 10.2147/TRRM.S366213
62
Carlos Cervera, Mercé Gurguí, Carlos Lumbreras. Factores de riesgo de la enfermedad por citomegalovirus en el receptor de un trasplante de órgano sólidoEnfermedades Infecciosas y Microbiología Clínica 2011; 29: 11 doi: 10.1016/S0213-005X(11)70051-9
63
Maddalena Giannella, Michele Bartoletti, Pierluigi Viale. Abdominal Solid Organ Transplantation2015; : 33 doi: 10.1007/978-3-319-16997-2_2
64
Raymund R. Razonable, James Y. Findlay, Aisling O'Riordan, S. Gordon Burroughs, R. Mark Ghobrial, Banwari Agarwal, Andrew Davenport, Michael Gropper. Critical care issues in patients after liver transplantationLiver Transplantation 2011; 17(5): 511 doi: 10.1002/lt.22291
65
Tricia A Bal, Glenn Armstrong, Xiang Y Han. Evaluation of the IMMULITE® 2000 CMV IgM assayHerpesviridae 2012; 3(1): 2 doi: 10.1186/2042-4280-3-2
66
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 253 doi: 10.1007/978-94-007-7693-7_40
67
Siddharth Sood, Craig Haifer, Lijia Yu, Julie Pavlovic, Paul J. Gow, Robert M. Jones, Kumar Visvanathan, Peter W. Angus, Adam G. Testro. Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantationLiver Transplantation 2015; 21(12): 1478 doi: 10.1002/lt.24216
68
J.G. Katsolis, W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, T.A. Gonwa, W.C. Hellinger. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high‐risk patientsTransplant Infectious Disease 2013; 15(2): 171 doi: 10.1111/tid.12050
69
A. Kahraman, K. Herzer. Labordiagnostische Überwachung nach LebertransplantationDer Gastroenterologe 2014; 9(2): 112 doi: 10.1007/s11377-013-0836-5
70
Chalermrat Bunchorntavakul, K. Rajender Reddy. Epstein-Barr Virus and Cytomegalovirus Infections of the LiverGastroenterology Clinics of North America 2020; 49(2): 331 doi: 10.1016/j.gtc.2020.01.008
71
D.J. Winston, F. Saliba, E. Blumberg, M. Abouljoud, J.B. Garcia-Diaz, J.A. Goss, L. Clough, R. Avery, A.P. Limaye, B.G. Ericzon, M. Navasa, R.I. Troisi, H. Chen, S.A. Villano, M.E. Uknis. Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled TrialAmerican Journal of Transplantation 2012; 12(11): 3021 doi: 10.1111/j.1600-6143.2012.04231.x
72
Maristela Pinheiro Freire, Isabel C. V. Soares Oshiro, Patricia Rodrigues Bonazzi, Thais Guimarães, Estela Regina Ramos Figueira, Telésforo Bacchella, Silvia Figueiredo Costa, Luiz Augusto Carneiro D'Albuquerque, Edson Abdala. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: An analysis of the epidemiology, risk factors, and outcomesLiver Transplantation 2013; 19(9): 1011 doi: 10.1002/lt.23682
73
Raymund R. Razonable. Cytomegalovirus infection after liver transplantationLiver Transplantation 2010; 16(S2): S45 doi: 10.1002/lt.22144
74
Lindsay A. Sobotka, Khalid Mumtaz, Michael R. Wellner, Sean G. Kelly, Lanla F. Conteh, A. James Hanje, Austin Schenk, Ashraf El-Hinnawi, Sylvester Black, Kenneth Washburn, Todd Pesavento, Reem Daloul, Anthony J. Michaels. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysisAnnals of Hepatology 2021; 24: 100318 doi: 10.1016/j.aohep.2021.100318
75
Kris V. Kowdley. Netter's Gastroenterology2010; : 637 doi: 10.1016/B978-1-4377-0121-0.50248-8
76
Peter D. Yoon, Madhukar S. Patel, Carla F. Murillo Perez, Tommy Ivanics, Marco P.A.W. Claasen, Hala Muaddi, David Wallace, Bettina Hansen, Gonzalo Sapisochin, Yu-Chen Fan. Outcomes of Adult Liver Retransplantation: A Canadian National Database AnalysisCanadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/9932631
77
Alyssa K. Mezochow, Douglas E. Schaubel, Eliot G. Peyster, James D. Lewis, David S. Goldberg, Therese Bittermann. Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiariesTransplant Infectious Disease 2024; 26(4) doi: 10.1111/tid.14317
78
J.M. Kim, S.J. Kim, J.-W. Joh, M. Shin, E.Y. Kim, J.I. Moon, G.O. Jung, G.-S. Choi, C.H.D. Kwon, S.-K. Lee. Preemptive Therapy in Adult Liver Transplant Recipients in CMV-Endemic AreaTransplantation Proceedings 2010; 42(3): 825 doi: 10.1016/j.transproceed.2010.02.026
79
Mina M. Benjamin, Kevin J. Dasher, James F. Trotter. A Comparison of Outcomes Between OKT3 and Antithymocyte Globulin for Treatment of Steroid-Resistant Rejection in Hepatitis C Liver Transplant RecipientsTransplantation 2014; 97(4): 470 doi: 10.1097/01.TP.0000435701.54019.98
80
Gadi Lalazar, Yaron Ilan. Liver Immunology2014; : 159 doi: 10.1007/978-3-319-02096-9_12
81
Matteo Ravaioli, Flavia Neri, Tiziana Lazzarotto, Valentina Rosa Bertuzzo, Paolo Di Gioia, Giacomo Stacchini, Maria Cristina Morelli, Giorgio Ercolani, Matteo Cescon, Angela Chiereghin, Massimo Del Gaudio, Alessandro Cucchetti, Antonio D. Pinna. Immunosuppression Modifications Based on an Immune Response AssayTransplantation 2015; 99(8): 1625 doi: 10.1097/TP.0000000000000650
82
J. Sun, G. Cao, L. Zhang, Y. Zhang, Z. Zhao, J. Hu, Y. Ji. Human Cytomegalovirus (CMV) UL97 D605E Mutation Has a Higher Prevalence in Infants With Primary CMV Infection Compared With Transplant Recipients With CMV RecurrenceTransplantation Proceedings 2012; 44(10): 3022 doi: 10.1016/j.transproceed.2012.06.069
83
Sara Gredmark-Russ, Cecilia Söderberg-Nauclér. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathologyVirulence 2012; 3(7): 621 doi: 10.4161/viru.22239
84
Isabel Campos‐Varela, Emily A. Blumberg, Patricia Giorgio, Camille N. Kotton, Fauzi Saliba, Emmanuel Q Wey, Michael Spiro, Dimitri Aristotle Raptis, Federico Villamil. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendationsClinical Transplantation 2022; 36(10) doi: 10.1111/ctr.14631
85
Elizabeth Davis. Equine Internal Medicine2018; : 313 doi: 10.1016/B978-0-323-44329-6.00008-5
86
Juan Jose Caston, Luis Castells, Evaristo Varo, Miguel Angel Gomez, Manuel de la Mata, Isabel Campos-Varela, Carlos Lumbreras, Luisa Gonzalez-Dieguez, Joan Fabregat, Ignacio Herrero, Magdalena Salcedo, Gloria Sanchez-Antolín, Julian Torre-Cisneros. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver TransplantationTransplantation 2016; 100(3): 593 doi: 10.1097/TP.0000000000000912
87
Non-Neoplastic Diseases of the Liver2022; : 65 doi: 10.55418/9781933477183-2
88
Keith W. Hamilton, Emily A. Blumberg. Cytomegalovirus Infection in Liver Transplant RecipientsInfectious Diseases in Clinical Practice 2012; 20(1): 32 doi: 10.1097/IPC.0b013e31823c4817
89
A.M. Sampaio, A.C. Guardia, A. Milan, A.N. Sasaki, P.D. Andrade, S.H.A. Bonon, R.S.B. Stucchi, S.C. Botelho Costa, I.F.S.F. Boin. Co-infection and Clinical Impact of Human Herpesvirus 5 and 6 in Liver TransplantationTransplantation Proceedings 2012; 44(8): 2455 doi: 10.1016/j.transproceed.2012.07.034
90
Marlotte A.A. van der Veer, Negina Nangrahary, Dennis A. Hesselink, Nicole S. Erler, Herold J. Metselaar, Teun van Gelder, Sarwa Darwish Murad. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver TransplantationTransplantation 2019; 103(11): 2329 doi: 10.1097/TP.0000000000002680
91
Experimental and Clinical Transplantation 2015; 13(Suppl 1) doi: 10.6002/ect.mesot2014.O26
92
Steve Miller, Henrietta Seet, Yasmeen Khan, Carolyn Wright, Rohan Nadarajah. Comparison of QIAGEN Automated Nucleic Acid Extraction Methods for CMV Quantitative PCR TestingAmerican Journal of Clinical Pathology 2010; 133(4): 558 doi: 10.1309/AJCPE5VZL1ONZHFJ
93
Zeynep Burcin Yilmaz, Funda Memisoglu, Sami Akbulut. Management of cytomegalovirus infection after liver transplantationWorld Journal of Transplantation 2024; 14(3): 93209 doi: 10.5500/wjt.v14.i3.93209
94
Raymund R. Razonable. Emerging Infections 92014; : 129 doi: 10.1128/9781555816803.ch7
95
Suresh B. Boppana, William J. Britt. Human CytomegalovirusesMethods in Molecular Biology 2014; 1119: 311 doi: 10.1007/978-1-62703-788-4_17
96
Mark R. Schleiss, Stanley A. Plotkin. Plotkin's Vaccines2018; : 228 doi: 10.1016/B978-0-323-35761-6.00016-X
97
Carolin Lackner, Stefan G. Huebscher. PathologiePathologie 2020; : 437 doi: 10.1007/978-3-642-04557-8_13
98
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantationHepatology International 2024; 18(2): 299 doi: 10.1007/s12072-023-10629-3
99
Veerendra Sandur, George Therapondos. Problem‐Based Approach to Gastroenterology and Hepatology2012; : 202 doi: 10.1002/9781444346381.ch16
100
Julia Engstrom-Melnyk, Pedro L. Rodriguez, Olivier Peraud, Raymond C. Hein. Current and Emerging Technologies for the Diagnosis of Microbial InfectionsMethods in Microbiology 2015; 42: 161 doi: 10.1016/bs.mim.2015.04.005
101
Hanlin L. Wang, Christopher D. Anderson, Sean Glasgow, William C. Chapman, Jeffrey S. Crippin, Mathew Augustine, Robert A. Anders, Andres Roma. Pathology of Solid Organ Transplantation2009; : 199 doi: 10.1007/978-3-540-79343-4_8
102
André Luís Conde Watanabe, Mateus Silva Feijó, Vinícius Paulo Lima de Menezes, Mayara Regina Galdino-Vasconcelos, Jorge Luis Salinas Caballero, Gustavo Ferreira, Fernando Jorge, Natália Trevizoli, Luiz Gustavo Diaz, Priscila Brizolla de Campos, Gabriel Cajá, Raquel Ullmann, Ana Virgínia Figueira, Tiago Morato, Adriano Moraes, Juan Rafael Branez Pereira, Marcelo Perosa. 500 Consecutive Liver Transplants: The Outcomes of a New Transplantation Program in the Middle West of BrazilTransplantation Proceedings 2021; 53(1): 73 doi: 10.1016/j.transproceed.2020.06.044
103
Suresh B. Boppana, William J. Britt. Human CytomegalovirusesMethods in Molecular Biology 2021; 2244: 403 doi: 10.1007/978-1-0716-1111-1_19
104
Sameh Adel Fayek, Wana Mantipisitkul, Flavia Rasetto, Raghava Munivenkatappa, Rolf N. Barth, Benjamin Philosophe. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipientsHPB 2010; 12(10): 657 doi: 10.1111/j.1477-2574.2010.00226.x
105
Panagiotis Tryphonopoulos, Debbie Weppler, Michele I. Morris, Cristina Russo, Seigo Nishida, David M. Levi, Jang Moon, Akin Tekin, Gennaro Selvaggi, Eddie Island, Leopoldo Arosemena, Phillip Ruiz, Andreas G. Tzakis. The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center ExperienceTransplantation 2011; 92(9): 1051 doi: 10.1097/TP.0b013e31822eb1f9
106
Antonio Craxì, Rosa Di Stefano. Sherlock's Diseases of the Liver and Biliary System2011; : 427 doi: 10.1002/9781444341294.ch21
107
Conrad Rauber, Miriam Awad, Ronald Koschny, Peter Sauer, Arianeb Mehrabi, Philip Gath, Karl-Heinz Weiss, Daniel Nils Gotthardt, Christian Rupp. Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control studyClinics and Research in Hepatology and Gastroenterology 2020; 44(1): 38 doi: 10.1016/j.clinre.2019.05.005
108
Mark R. Schleiss, Stanley A. Plotkin. Vaccines2013; : 1032 doi: 10.1016/B978-1-4557-0090-5.00046-X
109
Divya Dahiya, Chen‐Fang Lee, Kun‐Ming Chan, Ting‐Jung Wu, Hong‐Shiue Chou, Shin‐Shin Cheng, Wei‐Chen Lee. A short‐term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantationJournal of Hepato-Biliary-Pancreatic Sciences 2011; 18(1): 32 doi: 10.1007/s00534-010-0286-0
110
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi. Textbook of Organ Transplantation2014; : 927 doi: 10.1002/9781118873434.ch82
111
Mark H. Kuniholm, Christina M. Parrinello, Kathryn Anastos, Michael Augenbraun, Michael Plankey, Marek Nowicki, Marion Peters, Elizabeth T. Golub, Nell Lurain, Alan L. Landay, Howard D. Strickler, Robert C. Kaplan, Julian W. Tang. Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected WomenPLoS ONE 2013; 8(4): e61973 doi: 10.1371/journal.pone.0061973
112
Christopher J. Damman, George B. McDonald. Transplant Infections2016; : 311 doi: 10.1007/978-3-319-28797-3_19
113
A. Verma, K. Palaniswamy, G. Cremonini, N. Heaton, A. Dhawan. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipientsPediatric Transplantation 2017; 21(3) doi: 10.1111/petr.12879
114
Michael S. Forman, Alexandra Valsamakis. Diagnostic Molecular Pathology in Practice2011; : 261 doi: 10.1007/978-3-642-19677-5_32
115
Nicolas J. Mueller, Jay A. Fishman. Medical Care of the Liver Transplant Patient2012; : 380 doi: 10.1002/9781444398441.ch34
116
Poornima Ramanan, Raymund R Razonable. Cytomegalovirus Infections in Solid Organ Transplantation: A ReviewInfection & Chemotherapy 2013; 45(3): 260 doi: 10.3947/ic.2013.45.3.260
117
Teresa Da Cunha, George Y. Wu. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised HostsJournal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00088
118
W. Ji, D.-S. Kim, S.-W. Jung, Y.-D. Yu, S.-O. Suh. Pre-emptive Therapy for the Cytomegalovirus Infection After Liver Transplantation in Endemic Areas and Its Optimal Diagnostic MethodTransplantation Proceedings 2013; 45(8): 3065 doi: 10.1016/j.transproceed.2013.08.042
119
Songpon Getsuwan, Pornthep Tanpowpong, Chatmanee Lertudomphonwanit, Jariya Chuthapisith, Napapat Butsriphum, Wasuntara Prabpram, Rarong Charoenmuang, Suporn Treepongkaruna. Health-Related Quality of Life in Pediatric Liver Transplant RecipientsTransplantation Proceedings 2021; 53(1): 141 doi: 10.1016/j.transproceed.2020.02.175
120
IfeanyiChukwu O. Onor, Sarah B. Todd, Erika Meredith, Sebastian D. Perez, Aneesh K. Mehta, G. Marshall Lyon, Stuart J. Knechtle, Steven I. Hanish. Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipientsTransplant International 2013; 26(6): 592 doi: 10.1111/tri.12101
121
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature ReviewTransplantation Proceedings 2018; 50(10): 4015 doi: 10.1016/j.transproceed.2018.05.014
122
Kyoung Yong Lee, Byung-Woo Yoo, Sung Soo Ahn, William Han Bae, Hyukmin Lee, Seung Min Jung, Sang-Won Lee, Yong-Beom Park, Jason Jungsik Song, Juliet V Spencer. Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCRPLOS ONE 2017; 12(7): e0181590 doi: 10.1371/journal.pone.0181590
123
Antoni Rimola, Miquel Navasa. Evidence‐Based Gastroenterology and Hepatology2010; : 724 doi: 10.1002/9781444314403.ch43
124
Elizabeth G. Davis, David E. Freeman, Joanne Hardy. Equine Infectious Diseases2014; : 1 doi: 10.1016/B978-1-4557-0891-8.00001-4
125
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation2019; : 593 doi: 10.1007/978-3-319-96400-3_34
126
M. Isabel Fiel, Thomas Schiano. Acute cellular rejection and its sequelae developing in a 42‐year‐old man after liver transplantation†Hepatology 2009; 50(2): 650 doi: 10.1002/hep.23161
127
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted childrenWorld Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
128
Raymund R Razonable. Immune-Based Therapies for Cytomegalovirus InfectionImmunotherapy 2010; 2(1): 117 doi: 10.2217/imt.09.82
129
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplantTransplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
130
M. Papachristou, A. Fylaktou, M. Daoudaki, E. Cholongitas, T. Karampatakis, A. Anastasiou, G. Chatzika, F. Makrovasili, L. Vagiotas, K. Karakasi, I. Fouzas. Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver TransplantationTransplantation Proceedings 2019; 51(2): 424 doi: 10.1016/j.transproceed.2019.01.074
131
Masami Minemura, Kazuto Tajiri, Yukihiro Shimizu. Liver involvement in systemic infectionWorld Journal of Hepatology 2014; 6(9): 632-642 doi: 10.4254/wjh.v6.i9.632
132
Gary C. Kanel. Atlas of Liver Pathology2024; : 445 doi: 10.1016/B978-0-323-82533-7.00013-2
133
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 603 doi: 10.1007/978-94-007-7675-3_32
134
Christina B. Planitzer, Marcus D. Saemann, Hartwig Gajek, Maria R. Farcet, Thomas R. Kreil. Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin PreparationsTransplantation 2011; 92(3): 267 doi: 10.1097/TP.0b013e318224115e
135
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan, Martina Sterneck. Selection and use of immunosuppressive therapies after liver transplantation: current German practiceClinical Transplantation 2016; 30(5): 487 doi: 10.1111/ctr.12708
136
Ann-Kristin Traska, Tobias Max Nowacki, Richard Vollenberg, Florian Rennebaum, Jörn Arne Meier, Tina Schomacher, Sara Noemi Reinartz Groba, Julia Fischer, Jonel Trebicka, Phil-Robin Tepasse. Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant PatientsCells 2024; 13(9): 741 doi: 10.3390/cells13090741
137
Jackrapong Bruminhent, Raymund R Razonable. Management of cytomegalovirus infection and disease in liver transplant recipientsWorld Journal of Hepatology 2014; 6(6): 370-383 doi: 10.4254/wjh.v6.i6.370
138
Chian Yong Low, Seyed Mohammadmehdi Hosseini‐Moghaddam, Coleman Rotstein, Eberhard L. Renner, Shahid Husain. The effect of different immunoprophylaxis regimens on post‐transplant cytomegalovirus (CMV) infection in CMV‐seropositive liver transplant recipientsTransplant Infectious Disease 2017; 19(5) doi: 10.1111/tid.12736
139
Raymund Rabe Razonable. Management of Cytomegalovirus Infection After Renal TransplantationInfectious Diseases in Clinical Practice 2009; 17(4): 220 doi: 10.1097/IPC.0b013e31819b8d27
140
Omar Jesus BenMarzouk-Hidalgo, Elisa Cordero, Almudena Martín-Peña, Elena García-Prado, Miguel Angel Gentil, Miguel Angel Gomez-Bravo, Lydia Barrera-Pulido, Jose Miguel Cisneros, Pilar Perez-Romero. Prevention of cytomegalovirus disease using preemptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infectionAntiviral Therapy 2009; 14(5): 641 doi: 10.1177/135965350901400509
141
Siroj Dejhansathit, Adam Michael Miller, Attaya Suvannasankha. Multiple ‘doughnut’ granulomas in a liver transplant patient with CMV reactivationBMJ Case Reports 2018; 11(1): e227252 doi: 10.1136/bcr-2018-227252
142
S. M. Miescher, T. M. Huber, M. Kühne, P. Lieby, D. R. Snydman, J. L. Vensak, M. Berger. In vitro evaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulinsVox Sanguinis 2015; 109(1): 71 doi: 10.1111/vox.12246
143
Yuanyi Mang, Yang Gao, Yan Yang, Mei Dong, Qian Yang, Hong Li, Jianghua Ran, Li Li, Jun Ma, Guoyu Chen, Bin Yang, Ying Xie, Yunsong Wu, Yingpeng Zhao, Shengning Zhang. Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case SeriesTransplantation Direct 2024; 10(4): e1598 doi: 10.1097/TXD.0000000000001598
144
Marta Bodro, Núria Sabé, Laura Lladó, Carme Baliellas, Jordi Niubó, Jose Castellote, Joan Fabregat, Antoni Rafecas, Jordi Carratalà. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipientsLiver Transplantation 2012; 18(9): 1093 doi: 10.1002/lt.23460
145
A. Milan, A.M. Sampaio, A.C. Guardia, C.R. Pavan, P.D. Andrade, S.H.A. Bonon, S.C.B. Costa, E. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi. Monitoring and Detection of Cytomegalovirus in Liver Transplant RecipientsTransplantation Proceedings 2011; 43(4): 1360 doi: 10.1016/j.transproceed.2011.02.031
146
W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, W.C. Hellinger. Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk RecipientsAmerican Journal of Transplantation 2011; 11(10): 2181 doi: 10.1111/j.1600-6143.2011.03618.x
147
Blanca C Lizaola-Mayo, Eduardo A Rodriguez. Cytomegalovirus infection after liver transplantationWorld Journal of Transplantation 2020; 10(7): 183-190 doi: 10.5500/wjt.v10.i7.183
148
Kathleen M. Doss, Catherine E. Kling, Madeleine R. Heldman, Nina Singh, Marilyn Wagener, Robert M. Rakita, Cynthia E. Fisher, Ajit P. Limaye. Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR)Transplant Infectious Disease 2023; 25(2) doi: 10.1111/tid.14015
149
Wendelyn Bosch, Michael G. Heckman, Surakit Pungpapong, Nancy N. Diehl, Jefree A. Shalev, Walter C. Hellinger. Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver TransplantationTransplantation 2012; 93(7): 723 doi: 10.1097/TP.0b013e3182472876
150
Alyson N. Fox, Robert S. Brown. Yamada' s Textbook of Gastroenterology2015; : 2129 doi: 10.1002/9781118512074.ch108
151
Wojciech Błogowski. Facial transplantation as an option in reconstructive surgery: no mountains too high?ANZ Journal of Surgery 2009; 79(12): 892 doi: 10.1111/j.1445-2197.2009.05140.x
152
Joachim Denner, Annette Mankertz. Porcine Circoviruses and XenotransplantationViruses 2017; 9(4): 83 doi: 10.3390/v9040083
153
Romil Saxena, Swan N. Thung. Practical Hepatic Pathology: A Diagnostic Approach2011; : 599 doi: 10.1016/B978-0-443-06803-4.00042-3
154
Prem N. Patel, Ahmed M. Alkaliby, Mitul C. Mehta, Angeline L. Wang. CMV retinitis in patients on mycophenolate immunosuppression: a report of two casesAllergy, Asthma & Clinical Immunology 2023; 19(1) doi: 10.1186/s13223-023-00817-z
155
Anne M. Larson, George B. McDonald. Transplant Infections2016; : 653 doi: 10.1007/978-3-319-28797-3_36
156
Timothy M. Schmitt, Melissa Phillips, Robert G. Sawyer, Patrick Northup, Klaus D. Hagspiel, Timothy L. Pruett, Hugo J. R. Bonatti. Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection Following Liver TransplantationDigestive Diseases and Sciences 2010; 55(11): 3224 doi: 10.1007/s10620-010-1149-x
157
Manav Wadhawan, Subash Gupta, Neerav Goyal, Karisangal R. Vasudevan, Kausar Makki, Reetika Dawar, Raman Sardana, Nand Lal, Ajay Kumar. Cytomegalovirus infection: Its incidence and management in cytomegalovirus‐seropositive living related liver transplant recipients: A single‐center experienceLiver Transplantation 2012; 18(12): 1448 doi: 10.1002/lt.23540
158
Amy W. Liu, Kamonwan Jutivorakool, Cynthia E. Fisher, Robert M. Rakita, Jorge D. Reyes, Renuka B. Bhattacharya, Keith R. Jerome, Ajit P. Limaye. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant RecipientsTransplantation 2018; 102(4): 632 doi: 10.1097/TP.0000000000002029
159
Richard R Watkins, Tracy L Lemonovich, Raymund R Razonable. Immune response to CMV in solid organ transplant recipients: current concepts and future directionsExpert Review of Clinical Immunology 2012; 8(4): 383 doi: 10.1586/eci.12.25
160
Jasmine Riviere Marcelin, Elena Beam, Raymund R Razonable. Cytomegalovirus infection in liver transplant recipients: Updates on clinical managementWorld Journal of Gastroenterology 2014; 20(31): 10658-10667 doi: 10.3748/wjg.v20.i31.10658
161
Yuval Ishay, Yaron Ilan. Liver Immunology2020; : 227 doi: 10.1007/978-3-030-51709-0_15